Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
OneSource Specialty Pharma, a multi-modality specialty pharma CDMO, and Formyco...
How has the launch of GLP-1 medication disrupted weight loss/obesity care model...
Leiutis Pharmaceuticals LLP has announced that the Central Drugs Standard Contr...
Company to launch once-weekly injectable for adults with type 2 diabetes in the...
The Ministry of Health of the Republic of Indonesia (BKPM) has issued a fraction...
The new approvals for the anti-programmed death-1 (PD-1) therapies cover both ne...
Professor Sulev Koks from the Personalised Medicine Centre has been awarded a N...
Everyone is talking about GLP-1 as the next big healthcare disruptor. That is o...
Under the deal, Teva will hold exclusive rights to commercialise both intravenou...
The company signed the agreement to test the investigational therapy with Eunice...
Pharmaceutical companies are experiencing a substantial transformation compared...
Facilitated by Ramot, which manages technology transfer for Tel Aviv University,...
AstraZeneca will obtain a licence to develop, manufacture and commercialise the ...
Godavari Biorefineries has been granted a patent by the Japan Patent Office for...
Cetaphil, the globally trusted skincare brand from Swiss dermatology company Ga...
Novo Nordisk India announced the launch of Awiqli (insulin icodec) in India — t...